Recombinant Human Alpha-Synuclein/SNCA Protein (Active) | PKSH033771

Recombinant Human Alpha-Synuclein/SNCA Protein (Active) | PKSH033771 | Gentaur US, UK & Europe Disrtribition

Synonyms: Alpha-Synuclein; Non-A Beta Component of AD Amyloid; Non-A4 Component of Amyloid Precursor; NACP; SNCA; NACP; PARK1

Active Protein: Active protein

Activity: Recombinant Human SLAMF6 is produced by our E.coli expression system and the target gene encoding Met1-Ala140 is expressed.

Protein Construction: Recombinant Human SLAMF6 is produced by our E.coli expression system and the target gene encoding Met1-Ala140 is expressed.

Fusion Tag: N/A

Species: Human

Expressed Host: E.coli

Shipping: This product is provided as lyophilized powder which is shipped with ice packs.

Purity: > 95 % as determined by reducing SDS-PAGE.

Endotoxin: < 1.0 EU per μg as determined by the LAL method.

Stability and Storage: Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.

Molecular Mass: 14.46 kDa

Formulation: Lyophilized from a 0.2 μm filtered solution of PBS, PH7.4.

Reconstitution: Please refer to the printed manual for detailed information.

Background: Alpha-Synuclein (SNCA) is a member of the Synuclein family. SNCA is expressed principally in brain but also expressed in low concentrations in all tissues except liver. SNCA interacts with UCHL1; Phospholipase D and histones. SNCA can include beta- and gamma-synuclein. In addition; SNCA is an important regulatory component of vesicular transport in neuronal cells. It has been suggested that SNCA is related to the pathogenesis of Parkinson's Disease and neurodegenerative disorders. Defects in SNCA will lead to Dementia Lewy Body (DLB).

Research Area: Neuroscience